CPRX Financial Facts

Loss from operations: -4.9M
Loss per share - basic and diluted: -0.06
See Full Income Statement

Total assets: 68.34M
Accrued expenses and other liabilities, non-current: 12.45K
See Full Balance Sheet

Catalyst Pharmaceutical Partners Inc. (CPRX) Earnings

  |   Expand Research on CPRX
Next EPS Date 11/16/15 *Est. EPS Growth Rate -20.0% *Last Qtr.
Average EPS % Beat Rate +10.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.9% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/15 Q215 -$0.06-$0.08 +$0.02N/AN/A N/A Details
5/11/15 Q115 -$0.07-$0.09 +$0.02N/AN/A N/A Details
3/16/15 Q414 -$0.06-$0.07 +$0.01N/AN/A N/A Details
11/14/14 Q314 -$0.06-$0.05 -$0.01N/AN/A N/A Details
8/14/14 Q214 -$0.05-$0.07 +$0.02N/AN/A N/A Details
5/16/14 Q114 -$0.07-$0.06 -$0.01N/AN/A N/A Details
3/19/14 Q413 $0.00-$0.07 +$0.07N/AN/A N/A Details
11/14/13 Q313 -$0.07-$0.07 $0.00N/AN/A N/A Details